Immune regulation in type 1 diabetes

Journal of Autoimmunity

Volumn 9, Issue 2, 1996, Pages 263-269

  Shimada, Akira ^a   Charlton, Brett ^a   Rohane, Patricia ^a   Taylor Edwards, Cariel ^a   Fathman, C Garrison ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD45RB; Cytokine; IDDM; NOD mouse; NOD scid; Scid

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; HELPER CELL; HYPERGLYCEMIA; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MEMORY CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029900662     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0033     Document Type: Conference Paper

References (35)

1. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13
2. Prochazka M., Gaskins H.R., Shultz L.D., Leiter E.H. 1992. The nonobese diabetic seid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89: 3290-3294
3. Rohane P.W., Shimada A., Kim D.T., Edwards C.T., Charlton B., Schultz L.D., Fathman G.G. 1995. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44: 550-554
4. Shimada A., Rohane P., Fathman G.G., Charlton B. 1996. Pathogenic and protective roles of CD45RBlow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45: 71-78
5. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T.E., Miller J.F. 1990. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345: 724-726
6. Slattery R.M., Miller J.F., Heath W.R., Charlton B. 1993. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 90: 10808-10810
7. Miltenyi S., Muller W., Weichel W., Radbruch A. 1990. High gradient magnetic cell separation with MACS. Cytometry 11: 231-238
8. Powrie F., Mason D. 1990. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. 172: 1701-1708
9. Fowell D., Mason D. 1993. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177: 627-636
10. Morrissey P.J., Charrier K., Braddy S., Liggitt D., Watson J.D. 1993. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 178: 237-244
11. Powrie F., Correa-Oliveira R., Mauze S., Coffman R.L. 1994. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179: 589-600
12. Boitard C., Yasunami R., Dardenne M., Bach J.F. 1989. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169: 1669-1680
13. Hutchings P.R., Cooke A. 1990. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun. 3: 175-185
14. Chosich N., Harrison L.C. 1993. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Diabetologia 36: 716-721
15. Sempe P., Richard M.-F., Bach J.-F., Boitard C. 1994. Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37: 337-343
16. Koike T., Itoh Y., Ishii T., Ito I., Takabayashi K., Maruyama N., Tomioka H., Yoshida S. 1987. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36: 539-541
17. Shizuru J.A., Taylor-Edwards C., Banks B.A., Gregory A.K., Fathman C.G. 1988. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240: 659-662
18. Wang Y., Hao L., Gill R.G., Lafferty K.J. 1987. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36: 535-538
19. Miller B.J., Appel M.C., O'Neil J.J., Wicker L.S. 1988. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140: 52-58
20. Yagi H., Matsumoto M., Kunimoto K., Kawaguchi J., Makino S., Harada M. 1992. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur. J. Immunol. 22: 2387-2393
21. Scott B., Liblau R., Degermann S., Marconi L.A., Ogata L., Caton A.J., McDevitt H.O., Lo D. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity Immunity 1: 73-79
22. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821
23. Healey D., Ozegbe P., Arden S., Chandler P., Hutton J., Cooke A. 1995. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95: 2979-2985
24. Katz J.D., Benoist C., Mathis D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188
25. Bergman B., Haskins K. 1994. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43: 197-203
26. Daniel D., Gill R.G., Schloot N., Wegmann D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062
27. Campbell I.L., Kay T. W., Oxbrow L., Harrison L.C. 1991. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87: 739-742
28. Shehadeh N.N., LaRosa F., Lafferty K.J. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6: 291-300
29. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C., Power R.F. 1995. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154: 4874-4882
30. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. 1994. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37: 1154-1158
31. Serreze D.V., Leiter E.H. 1988. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J. Immunol. 140: 3801-3807
32. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87-99
33. Eisenbarth G.S. 1986. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
34. Signore A., Procaccini E., Toscano A.M., Ferretti E., Williams A.J., Beales P.E., Cugini P., Pozzilli P. 1994. Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 101: 263-269
35. Chatenoud L., Thervet E., Primo J., Bach J.F. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91: 123-127